U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
VISUGROMAB
INN  
Official Name English
CTL-002
Code English
Visugromab [WHO-DD]
Common Name English
visugromab [INN]
Common Name English
IMMUNOGLOBULIN G4 (226-PROLINE,DE-445-LYSINE), ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CTL-002 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
NCI_THESAURUS
C179558
Created by admin on Sat Dec 16 19:09:35 GMT 2023 , Edited by admin on Sat Dec 16 19:09:35 GMT 2023
PRIMARY
FDA UNII
NX3NW9MM9W
Created by admin on Sat Dec 16 19:09:35 GMT 2023 , Edited by admin on Sat Dec 16 19:09:35 GMT 2023
PRIMARY
INN
12044
Created by admin on Sat Dec 16 19:09:35 GMT 2023 , Edited by admin on Sat Dec 16 19:09:35 GMT 2023
PRIMARY
CAS
2556646-63-8
Created by admin on Sat Dec 16 19:09:35 GMT 2023 , Edited by admin on Sat Dec 16 19:09:35 GMT 2023
PRIMARY
SUBSTANCE RECORD
VISUGROMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966